@lisag_oc: JAMA just released a cohort study of over 60,000 patients taking either semaglutide or trezepatide. They found the patient treated with GLP ones were 37% less likely to develop dementia and their counter parts on other anti-diabetic medications. #dementia #alzheimers #glp1 #clinical #MentalHealth